Estradiol vs Testosterone Cypionate
Estradiol and Testosterone Cypionate are both hormone compounds evaluated on Vial: Estradiol is FDA approved with clinical-trial evidence, and Testosterone Cypionate is FDA approved with FDA-approval-level clinical evidence, offered by 8 and 25 verified providers respectively.
Vial summary · compiled from public records
At a glance
Estradiol
Sold as Estrace, Climara
- Category
- Hormone
- FDA / legal status
- FDA Approved
- Route
- Oral, transdermal, injectable
Testosterone Cypionate
Sold as Depo-Testosterone
- Category
- Hormone
- FDA / legal status
- FDA Approved
- Route
- Intramuscular, subcutaneous
Side by side
| Field | Estradiol | Testosterone Cypionate |
|---|---|---|
| Category | Hormone | Hormone |
| Brand names | Estrace, Climara | Depo-Testosterone |
| FDA / legal status | FDA Approved | FDA Approved |
| Evidence tier | Clinical Trials | FDA Approved |
| Administration route | Oral, transdermal, injectable | Intramuscular, subcutaneous |
| Compounding access | FDA-approved product, dispensed by prescription | FDA-approved product, dispensed by prescription |
| Providers on Vial | 8 listed | 25 listed |
| Typical price band | $$ | $$ to $$$ |
Verified providers offering each
Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
About each compound
About Estradiol
Estradiol is the primary biologically active estrogen and is the cornerstone of female hormone replacement therapy for menopause management. It protects against cardiovascular disease, osteoporosis, cognitive decline, and urogenital atrophy. Transdermal delivery avoids first-pass metabolism and provides more stable levels than oral estrogen. It is used in optimization medicine to maintain youthful estradiol levels in perimenopausal and postmenopausal women.
About Testosterone Cypionate
A synthetic ester of testosterone, testosterone cypionate is an intramuscularly or subcutaneously administered androgen that provides sustained release of the hormone over approximately one to two weeks. It binds to androgen receptors throughout the body, promoting protein synthesis, muscle development, bone density maintenance, and secondary sex characteristics. The compound is primarily used in the treatment of male hypogonadism and as a component of gender-affirming hormone therapy.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.